Mucaram, Laysa S.
HRN: 25-63-83 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2024
CEFUROXIME 1.5GM (VIAL)
08/11/2024
08/17/2024
IVTT
1.5g
Q8
UTI
Waiting Final Action
08/12/2024
CEFUROXIME 500MG (TAB)
08/12/2024
08/18/2024
PO
500mg
BID
UTI
Waiting Final Action